Literature DB >> 9466686

In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha.

P Randhawa1, T Whiteside, A Zeevi, M Nalesnik, C Alvares, S M Gollin, J Demetris, J Locker.   

Abstract

Epstein-Barr-virus-associated posttransplant lymphoproliferative disease ranges from transient lymphadenitis to aggressive lymphoma. This study characterizes an in vitro model to study the pathogenesis of this disease with a cell culture system. Five B-cell lines derived from posttransplant lymphoproliferative disease tissue were characterized with regard to immunophenotype, karyotype, molecular genetics, cytokine production, and growth regulation. All cell lines expressed CD19, CD21, CD22, CD43, and CD77, but not CD10 antigens. Immunoglobulin light chain restriction was seen in four of five cell lines, and cytogenetic abnormalities were demonstrable in three of the five. Cells proliferating in culture contained multiple Epstein-Barr virus episomes and showed lytic viral replication. All cell lines produced tumor necrosis factor-beta and interleukin-10 without evidence of autocrine growth regulatory loops involving these cytokines. No evidence of IL-1 alpha, IL-2, IL-4, IL-5 or IL-6 production was found by reverse transcriptase polymerase chain reaction. Adding 500 U IFN-alpha/ml to the culture medium resulted in 30% inhibition of [3H]thymidine incorporation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9466686     DOI: 10.1007/s11626-997-0160-9

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.723


  44 in total

1.  Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.

Authors:  D Benjamin; T J Knobloch; M A Dayton
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

Review 2.  Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma.

Authors:  K Nilsson; G Klein
Journal:  Adv Cancer Res       Date:  1982       Impact factor: 6.242

3.  The participation of tumor necrosis factor in the pathogenesis of lung allograft rejection in the rat.

Authors:  R Saito; J Prehn; X J Zuo; A Marchevesky; J Castracane; P Waters; J Matloff; S C Jordan
Journal:  Transplantation       Date:  1993-05       Impact factor: 4.939

4.  Induction of TNF alpha and TNF beta gene expression in rat cardiac transplants during allograft rejection.

Authors:  T T Pizarro; K Malinowska; E J Kovacs; J Clancy; J A Robinson; L A Piccinini
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

5.  IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.

Authors:  A M Liberati; M Schippa; M G Portuesi; M Grazia Proietti; V De Angelis; A Ferrajoli; S Cinieri; F Di Clemente; L Palmisano; P Berruto
Journal:  Haematologica       Date:  1991 Sep-Oct       Impact factor: 9.941

6.  Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas.

Authors:  D E Picarella; A Kratz; C B Li; N H Ruddle; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

7.  Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders.

Authors:  H Cen; P A Williams; H P McWilliams; M C Breinig; M Ho; J L McKnight
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

8.  The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation.

Authors:  D W Hanto; K Sakamoto; D T Purtilo; R L Simmons; J S Najarian
Journal:  Surgery       Date:  1981-08       Impact factor: 3.982

9.  Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.

Authors:  C M Rooney; C D Gregory; M Rowe; S Finerty; C Edwards; H Rupani; A B Rickinson
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

10.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  1 in total

1.  Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders.

Authors:  M A Nalesnik; A Zeevi; P S Randhawa; A Faro; K J Spichty; A J Demetris; J J Fung; T L Whiteside; T E Starzl
Journal:  Clin Transplant       Date:  1999-02       Impact factor: 2.863

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.